Market Place
Sourcing Support
Cadila Pharma Unveils Triple Therapy for BP Control
10 Apr 2026 //
INDPHARMAPOST
Cadila Pharma Celebrates 75-Year Global Healthcare Innovation
16 Mar 2026 //
INDPHARMAPOST
Cadila Pharma Celebrates 75 Years In Healthcare
12 Mar 2026 //
EXPRESSPHARMA
AAPI, Cadila Pharma host forum on Ayurveda’s role
13 Jan 2026 //
EXPRESSPHARMA
Cadila Pharma Launches Rosmi F Tablet For Mixed Dyslipidemia
17 Nov 2025 //
EXPRESSPHARMA
Cadila Launches Allergy Relief Tablet Dlorfast-M
13 Oct 2025 //
INDPHARMAPOST
Cadila Pharma Launches Nu Nutridac Capsule For Anxiety Disorders
16 Sep 2025 //
EXPRESSPHARMA
Cadila Pharmaceuticals Launches Vasograin Plus for Migraines
06 Aug 2025 //
INDPHARMAPOST
Cadila Pharma Releases Bilacad Dex Syrup
01 Jul 2025 //
EXPRESSPHARMA
Cadila Pharmaceuticals launches Empadon
28 May 2025 //
EXPRESSPHARMA
Cadila Pharmaceuticals launches Vasograin EC for migraine relief
08 Apr 2025 //
EXPRESSPHARMA
Cadila Expands Warehouse to Boost Logistics, Market Reach
25 Feb 2025 //
EXPRESS PHARMA
Cadila Pharmaceuticals launches iron supplement ‘Militol’
14 Nov 2024 //
EXPRESSPHARMA
CII recognized Cadila among Top 50 Innovative Companies in India
19 Dec 2023 //
INDIAN PHARMA POST
Cadila Pharma appoints Ashraf Allam as Global COO
20 Dec 2022 //
EXPRESSPHARMA
Cadila Pharma appoints Ashraf Allam global COO
19 Dec 2022 //
ECONOMIC TIMES
Cadila Pharma appoints Ashraf Allam global COO
19 Dec 2022 //
ECONOMIC TIMES
Cadila Pharmaceuticals signs IIF with Odisha Government
08 Dec 2022 //
INDIANPHARMAPOST
Cadila recognized for its contribution to leprosy treatment
15 Nov 2022 //
INDIANPHARMAPOST
Cadila launches generic versions of type 2 diabetes drug Sitagliptin in India
01 Aug 2022 //
ET HEALTH
Cadila launches ThRabis, world’s first novel three-dose rabies vaccine
08 Apr 2022 //
ET HEALTH
Cadila Pharmaceuticals expands oncology portfolio, launches Tarzed
06 Jan 2022 //
EXPRESSPHARMA
Enzychem and Cadila collaborate to produce Covid-19 vaccine in Korea
29 Nov 2021 //
PHARMACEUTICAL-TECHNOLOGY
Lipidor announces approval to start PhIII clinical study of AKP02
27 Sep 2021 //
PRNEWSWIRE
NPPA revises retail price of Cadila Pharma’s vitamin D3
24 Sep 2021 //
PHARMABIZ
Cadila Pharma launches triazole antifungal drug posaconazole
23 Jun 2021 //
PHARMABIZ
Pharma companies cut remdesivir injection prices on govt intervention: NPPA
19 Apr 2021 //
ECONOMIC TIMES
Zydus settles Revlimid patent litigation with Celgene
23 Mar 2021 //
PHARMABIZ
Cadila, one of India`s two Covid vaccine makers, is going in for a huge capacity
27 Oct 2020 //
ECONOMICTIMES
Cadila, one of India`s two Covid vaccine makers, is going
26 Oct 2020 //
INDIATIMES
Cadila Pharma launches Tikacad in India to reduce cardiovascular death
09 Oct 2020 //
PHARMABIZ
Cadila Pharmaceuticals Announces Launch of Fourth Biosimilar in Two Months
28 Aug 2020 //
BIGMOLECULEWATCH
Cadila Pharma launches Cadalimab (adalimumab biosimilar) for India
28 Aug 2020 //
EXPRESSPHARMA
Cadila Pharma launches fenticonazole nitrate vaginal capsules for vulvovaginal
14 Jul 2020 //
PHARMABIZ
Pharma companies involved in rolling out Covid-19 treatments face ESG
14 Jul 2020 //
ECONOMICTIMES
Cadila Pharma launches esomeprazole tablets for treatment of hyperacidity
13 Jul 2020 //
PHARMABIZ
Cadila Pharma launches anti allergic drug Bilastine in India
26 Jun 2020 //
PHARMABIZ
COVID-19: AIIMS Bhopal claims good results in drug trial
17 May 2020 //
ECONOMICTIMES
Coronavirus impact: Cadila Pharma shuts unit after several positive cases
08 May 2020 //
BUSINESSTODAY
Cadila share price surges 15% on USFDA approval for Perphenazine tablets
07 Apr 2020 //
MONEYCONTROL
Indian Immunologicals partners with Griffith University to develop COVID-19Vacc
07 Apr 2020 //
PR.MH UNIVERSITY TO 2
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
05 Apr 2020 //
REUTERS
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
05 Apr 2020 //
REUTERS
Cadila seeks nod to repurpose Hepatitis C drug for COVID-19 in India
04 Apr 2020 //
REUTERS
Cadila Pharma bags two awards for compliance
16 Oct 2019 //
PHARMABIZ
GSK to recall Ranitidine from India after regulator alert
26 Sep 2019 //
THEECONOMICTIMES
Zydus Cadila launches insomnia drug in US market
25 Jul 2019 //
ECONOMIC TIMES
Zydus Cadila gets tentative USFDA nod for generic acid-reflux drug
22 Jan 2019 //
HINDU BUSINESS LINE
Zydus Cadila gets USFDA nod for antipsychotic drug
09 Jan 2019 //
ECONOMIC TIMES
Zydus Cadila gets USFDA nod for generic cholesterol drug
23 Nov 2018 //
ECONOMIC TIMES
Zydus receives US FDA tentative approval to market Exjade tablets
20 Nov 2018 //
PHARMABIZ
Zydus Cadila gets USFDA nod for leukemia treatment injection
13 Nov 2018 //
ECONOMIC TIMES
Zydus Cadila launches generic erectile dysfunction drug in US
31 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets USFDA nod to market generic seizures treatment drug
23 Oct 2018 //
HINDU BUSINESS LINE
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus Cadila gets tentative USFDA nod for diabetes drug
11 Oct 2018 //
MONEY CONTROL
Zydus leads race for Complan with Rs 4,500-crore bid
10 Oct 2018 //
ECONOMIC TIMES
Zydus gets US FDA tentative approval for sitagliptin tablets
11 Sep 2018 //
PHARMABIZ
Domestic pharma players eye Bharat Serums acquisition
29 Aug 2018 //
ECONOMIC TIMES
